1-3 of 3
Alfonso Quintás-Cardama
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

What CAR Will Win the CD19 Race?

Alfonso Quintás-Cardama
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (3): 498–506.
https://doi.org/10.1158/1535-7163.MCT-18-1070
Published: 01 March 2019
View article titled, What CAR Will Win the CD19 Race?
Open the PDF for What CAR Will Win the CD19 Race? in another window
Journal Articles

Abstract B61: Bcr-Abl1 V304D mutation in CML: friend or foe?

Sabrina Pricl, Erik Laurini, Maurizio Fermeglia, Paola Storici, Barbara Giabbai, Marta Semrau, Matteo De March, Nicholas J. Donato, Alfonso Quintas-Cardama
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): B61.
https://doi.org/10.1158/1535-7163.TARG-15-B61
Published: 01 December 2015
View article titled, Abstract B61: Bcr-Abl1 V304D mutation in CML: friend or foe?
Journal Articles

Abstract B277: Polymutant BCR-ABL1 proteins during chronic myeloid leukemia therapy: Novel mechanisms of resitance from clinical, in vitro, and in silico evidence.

Sabrina Pricl, Don L. Gibbons, Paola Posocco, Erik Laurini, Barbara Giabbai, Paola Storici, Maurizio Fermeglia, Hunshi Sun, Jorge Cortes, Moshe Talpaz, Nicholas Donato, Alfonso Quintas-Cardama
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B277.
https://doi.org/10.1158/1535-7163.TARG-13-B277
Published: 01 November 2013
View article titled, Abstract B277: Polymutant BCR-ABL1 proteins during chronic myeloid leukemia therapy: Novel mechanisms of resitance from clinical, in vitro, and in silico evidence.